Why Won’t More Older Americans Get Their Covid Booster?

Approximately 1 in 3 Americans 65 and older who completed their initial vaccination round still have not received a first booster shot. The numbers dismay researchers, who say the lag has cost tens of thousands of lives.

Guía para entender a las subvariantes de ómicron

¿Qué tan diferentes son estas subvariantes entre sí? ¿Puede la infección por una subvariante proteger a alguien de la infección por otra? Y, ¿qué tan bien funcionan contra estas variantes las vacunas que se desarrollaron antes de la aparición de ómicron?

KHN’s ‘What the Health?’: More Covid Complications for Congress

Congress is back in session, but covid diagnoses for Vice President Kamala Harris and two Democratic senators have temporarily left the Senate without a working majority to approve continued covid funding. Meanwhile, opponents of the Affordable Care Act have filed yet another lawsuit challenging a portion of the law, and we say goodbye to the late Sen. Orrin Hatch of Utah, who left a long legacy of health laws. Rachel Cohrs of STAT News, Anna Edney of Bloomberg News, and Rebecca Adams of KHN join KHN’s Julie Rovner to discuss these issues and more.

Despite Losing Federal Money, California Is Still Testing Uninsured Residents for Covid — For Now

Federal funding that paid for covid testing, treatment, and vaccines for uninsured people has run out. While some states struggle to make up the difference, California is relying on other state and local programs to continue free testing.

Judge’s Ruling on the CDC Mask Mandate Highlights the Limits of the Agency’s Power

A recent court decision that overturns one of the Centers for Disease Control and Prevention’s few pandemic rules — masks required on public transportation — spotlights how little power remains in federal hands to enforce public health protections.

Why Cheap, Older Drugs That Might Treat Covid Never Get Out of the Lab

The hydroxychloroquine and ivermectin fiascoes have soured many doctors on repurposing drugs for covid. A few inexpensive old drugs may be as good as some of the new antivirals, but they face complex obstacles to get to patients.

How the Test-to-Treat Pillar of the US Covid Strategy Is Failing Patients

The federal “test-to-treat” program was designed to be a one-stop shop for people to get tested for covid and to receive treatment. But as covid cases rise again, many communities have no participating locations, and website bugs make it difficult to book an appointment at the biggest participant.

When Symptoms Linger for Weeks, Is It Long Covid?

Patients with symptoms that last three to 12 weeks after an acute covid infection should adopt a “watchful waiting” approach to recovery, an expert says. Keep in contact with a primary care doctor and take it easy.